00:00First of all, as you know, various variants and their impact on effectiveness of the COVID-19
00:05vaccine continues to be an important topic, not only for us, but also for regulators across
00:11the world. Last week, indeed, we had a constructive exchange with other regulatory authorities
00:18all over the world on how to deal with the variants that are emerging and for the development
00:25of new vaccines in the future. We are aware of the concerns that are caused by the rapid spread of
00:31the Delta variant and other variants. Right now, it seems that for the four vaccines that are approved
00:38in the European Union, they seem all to be protecting against all the strains that are
00:43circulated in Europe, including the Delta variant. The first data from real world evidence are showing
00:50that two doses of vaccines are protective against the Delta variant, and also data are showing that
00:58antibodies from the approved vaccines are able to neutralize the Delta variant too. So these data are reassuring.
Commenti